Table 2 Adverse events
Cohort 1 (n = 3) | Cohort 2 (n = 4) | Cohort 3 (n = 13) | Overall (n = 20) | |
|---|---|---|---|---|
n (%) | n (%) | n (%) | n (%) | |
Any AE | 3 (100.0) | 4 (100.0) | 13 (100.0) | 20 (100.0) |
Any AE of grade ≥ 3 | 3 (100.0) | 4 (100.0) | 12 (92.3) | 19 (95.0) |
Any TRAE | 1 (33.3) | 3 (75.0) | 1 (7.7) | 5 (25.0) |
Any TRAE of grade ≥ 3 | 0 | 1 (25.0) | 0 | 1 (5.0) |
Any TRAE leading to discontinuation | 0 | 0 | 0 | 0 |
Any TRAE leading to dose interruption | 0 | 0 | 0 | 0 |
Any TRAE leading to death | 0 | 0 | 0 | 0 |
